vs
COPT DEFENSE PROPERTIES（CDP）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是COPT DEFENSE PROPERTIES的1.1倍（$217.5M vs $197.4M），COPT DEFENSE PROPERTIES净利率更高（20.0% vs -20.7%，领先40.6%），COPT DEFENSE PROPERTIES同比增速更快（7.6% vs 3.1%），过去两年Tilray Brands, Inc.的营收复合增速更高（7.5% vs 1.1%）
COPT Defense Properties是一家专业房地产投资信托基金，重点投资写字楼物业，资产主要布局于华盛顿大都会区的近郊区域，核心租户为美国政府及国防军工行业企业。截至2024年12月31日，公司旗下共持有164栋写字楼，总面积达1650万平方英尺，同时运营31个单租户数据中心，总面积590万平方英尺。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
CDP vs TLRY — 直观对比
营收规模更大
TLRY
是对方的1.1倍
$197.4M
营收增速更快
CDP
高出4.5%
3.1%
净利率更高
CDP
高出40.6%
-20.7%
两年增速更快
TLRY
近两年复合增速
1.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $197.4M | $217.5M |
| 净利润 | $39.4M | $-44.9M |
| 毛利率 | — | 26.4% |
| 营业利润率 | 19.9% | -10.2% |
| 净利率 | 20.0% | -20.7% |
| 营收同比 | 7.6% | 3.1% |
| 净利润同比 | 8.0% | 47.4% |
| 每股收益（稀释后） | $0.32 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDPTLRY
| Q4 25 | $197.4M | $217.5M | ||
| Q3 25 | $188.8M | $209.5M | ||
| Q2 25 | $189.9M | $224.5M | ||
| Q1 25 | $187.9M | $185.8M | ||
| Q4 24 | $183.4M | $210.9M | ||
| Q3 24 | $189.2M | $200.0M | ||
| Q2 24 | $187.3M | $229.9M | ||
| Q1 24 | $193.3M | $188.3M |
净利润CDPTLRY
| Q4 25 | $39.4M | $-44.9M | ||
| Q3 25 | $43.7M | $-322.0K | ||
| Q2 25 | $40.2M | $-1.3B | ||
| Q1 25 | $36.2M | $-789.4M | ||
| Q4 24 | $36.5M | $-85.3M | ||
| Q3 24 | $37.4M | $-39.2M | ||
| Q2 24 | $36.4M | $-31.7M | ||
| Q1 24 | $33.7M | $-92.7M |
毛利率CDPTLRY
| Q4 25 | — | 26.4% | ||
| Q3 25 | — | 27.4% | ||
| Q2 25 | — | 30.1% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | — | 35.8% | ||
| Q1 24 | — | 26.2% |
营业利润率CDPTLRY
| Q4 25 | 19.9% | -10.2% | ||
| Q3 25 | 22.5% | 1.0% | ||
| Q2 25 | 21.0% | -643.1% | ||
| Q1 25 | 19.1% | -409.0% | ||
| Q4 24 | 19.7% | -20.0% | ||
| Q3 24 | 19.8% | -18.3% | ||
| Q2 24 | 19.4% | -7.2% | ||
| Q1 24 | 17.5% | -43.6% |
净利率CDPTLRY
| Q4 25 | 20.0% | -20.7% | ||
| Q3 25 | 23.2% | -0.2% | ||
| Q2 25 | 21.1% | -566.9% | ||
| Q1 25 | 19.3% | -424.9% | ||
| Q4 24 | 19.9% | -40.5% | ||
| Q3 24 | 19.8% | -19.6% | ||
| Q2 24 | 19.4% | -13.8% | ||
| Q1 24 | 17.4% | -49.2% |
每股收益（稀释后）CDPTLRY
| Q4 25 | $0.32 | $-0.41 | ||
| Q3 25 | $0.37 | $0.00 | ||
| Q2 25 | $0.34 | $7.26 | ||
| Q1 25 | $0.31 | $-8.69 | ||
| Q4 24 | $0.31 | $-0.99 | ||
| Q3 24 | $0.32 | $-0.04 | ||
| Q2 24 | $0.31 | $-0.04 | ||
| Q1 24 | $0.29 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $275.0M | $291.6M |
| 总债务越低越好 | $2.8B | — |
| 股东权益账面价值 | $1.5B | $1.6B |
| 总资产 | $4.7B | $2.1B |
| 负债/权益比越低杠杆越低 | 1.83× | — |
8季度趋势，按日历期对齐
现金及短期投资CDPTLRY
| Q4 25 | $275.0M | $291.6M | ||
| Q3 25 | $23.7M | $264.8M | ||
| Q2 25 | $21.3M | $256.4M | ||
| Q1 25 | $24.3M | — | ||
| Q4 24 | $38.3M | $252.2M | ||
| Q3 24 | $34.5M | $280.1M | ||
| Q2 24 | $100.4M | $260.5M | ||
| Q1 24 | $123.1M | $225.9M |
总债务CDPTLRY
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.4B | — |
股东权益CDPTLRY
| Q4 25 | $1.5B | $1.6B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $2.7B | ||
| Q4 24 | $1.5B | $3.5B | ||
| Q3 24 | $1.5B | $3.5B | ||
| Q2 24 | $1.5B | $3.4B | ||
| Q1 24 | $1.5B | $3.4B |
总资产CDPTLRY
| Q4 25 | $4.7B | $2.1B | ||
| Q3 25 | $4.4B | $2.1B | ||
| Q2 25 | $4.3B | $2.1B | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $4.3B | $4.2B | ||
| Q3 24 | $4.2B | $4.3B | ||
| Q2 24 | $4.2B | $4.2B | ||
| Q1 24 | $4.2B | $4.2B |
负债/权益比CDPTLRY
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.62× | — | ||
| Q2 25 | 1.63× | — | ||
| Q1 25 | 1.62× | — | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.61× | — | ||
| Q2 24 | 1.61× | — | ||
| Q1 24 | 1.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $309.9M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $288.9M | — |
| 自由现金流率自由现金流/营收 | 146.4% | — |
| 资本支出强度资本支出/营收 | 10.7% | — |
| 现金转化率经营现金流/净利润 | 7.87× | — |
| 过去12个月自由现金流最近4个季度 | $501.5M | — |
8季度趋势，按日历期对齐
经营现金流CDPTLRY
| Q4 25 | $309.9M | $-8.5M | ||
| Q3 25 | $68.6M | $-1.3M | ||
| Q2 25 | $87.9M | $-12.8M | ||
| Q1 25 | $72.1M | $-5.8M | ||
| Q4 24 | $331.0M | $-40.7M | ||
| Q3 24 | $65.1M | $-35.3M | ||
| Q2 24 | $93.8M | $30.7M | ||
| Q1 24 | $71.0M | $-15.4M |
自由现金流CDPTLRY
| Q4 25 | $288.9M | — | ||
| Q3 25 | $62.9M | — | ||
| Q2 25 | $84.5M | $-19.1M | ||
| Q1 25 | $65.1M | $-20.2M | ||
| Q4 24 | $299.6M | $-46.2M | ||
| Q3 24 | $61.0M | $-42.0M | ||
| Q2 24 | $88.4M | $21.0M | ||
| Q1 24 | $57.9M | $-24.9M |
自由现金流率CDPTLRY
| Q4 25 | 146.4% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 44.5% | -8.5% | ||
| Q1 25 | 34.7% | -10.9% | ||
| Q4 24 | 163.3% | -21.9% | ||
| Q3 24 | 32.3% | -21.0% | ||
| Q2 24 | 47.2% | 9.1% | ||
| Q1 24 | 30.0% | -13.2% |
资本支出强度CDPTLRY
| Q4 25 | 10.7% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 1.8% | 2.8% | ||
| Q1 25 | 3.7% | 7.8% | ||
| Q4 24 | 17.1% | 2.6% | ||
| Q3 24 | 2.1% | 3.4% | ||
| Q2 24 | 2.9% | 4.2% | ||
| Q1 24 | 6.8% | 5.1% |
现金转化率CDPTLRY
| Q4 25 | 7.87× | — | ||
| Q3 25 | 1.57× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 9.08× | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 2.58× | — | ||
| Q1 24 | 2.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDP
暂无分部数据
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
